Synthesis and antitumor activity of 3-[(methyl)bis(5-trialkylsilyl-furan-2-yl)silyl]propylamines

被引：4
|
作者：
Ignatovich, L. [1 ,2 ]
Romanov, V. [1 ,2 ]
Spura, J. [1 ,2 ]
Popelis, J. [1 ,2 ]
Domracheva, I. [1 ,2 ]
Shestakova, I. [1 ,2 ]
机构：
[1] Latvian Inst Organ Synth, LV-1006 Riga, Latvia
[2] Latvian Inst Organ Synth, LV-1006 Riga, Latvia
来源：
CHEMISTRY OF HETEROCYCLIC COMPOUNDS | 2012年 / 47卷 / 12期
关键词：
3-[(methyl)bis(5-trialkylsilylfuran-2-yl)silyl]propylamines; cytotoxicity; hydrosilylation; ESTROGEN-RECEPTOR MODULATORS; CYTOTOXIC ACTIVITY; BREAST-CANCER; ARZOXIFENE; AGENTS; INHIBITOR; GEFITINIB; PIPELINE; FRESH; DRUG;
D O I：
10.1007/s10593-012-0940-3
中图分类号：
O62 [有机化学];
学科分类号：
070303 ; 081704 ;
摘要：
Novel 3-[(methyl)bis(5-trialkylsilylfuran-2-yl)silyl]propylamines have been synthesized by a hydrosilylation reaction of aliphatic and heterocyclic N-allylamines in the presence of the Speier's catalyst. The effects of the structure of the amine and the alkyl substituent at the silicon atom on the cytotoxicity of the compounds have been studied.
引用
收藏
页码：1502 / 1508
页数：7
相关论文
共 50 条
  • [1] Synthesis and antitumor activity of 3-[(methyl)bis(5-trialkylsilyl-furan-2-yl)silyl]propylamines
    L. Ignatovich
    V. Romanov
    J. Spura
    J. Popelis
    I. Domracheva
    I. Shestakova
    Chemistry of Heterocyclic Compounds, 2012, 47 : 1502 - 1508
  • [2] Anticancer activity of novel 3-(furan-2-yl)pyrazolyl and 3-(thiophen-2-yl)pyrazolyl hybrid chalcones: Synthesis and in vitro studies
    Helmy, Mirna T.
    Sroor, Farid M.
    Mahrous, Karima F.
    Mahmoud, Khaled
    Hassaneen, Hamdi M.
    Saleh, Fatma M.
    Abdelhamid, Ismail A.
    Mohamed Teleb, Mohamed A.
    ARCHIV DER PHARMAZIE, 2022, 355 (03)
  • [3] Synthesis, Nematicidal and Antimicrobial activity of 3-(5-3-Methyl-5-[(3-methyl-7-5-[2-(aryl)-4-oxo-1,3-thiazolan-3-yl]-1,3,4-thiadiazol-2-ylbenzo[b]furan-5-yl)methyl]benzo[b]furan-7-yl-1,3,4-thiadiazol-2-yl)-2-(aryl)-1,3-thiazolan-4-one
    Reddy, Cherkilpally Sanjeeva
    Rao, Dasari Chandrashekar
    Yakub, Vookanti
    Nagaraj, Adki
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2010, 58 (06) : 805 - 810
  • [4] SYNTHESIS, TRANSFORMATION OF 3-[(4-ARYLTHIAZOL-2-YL)-(p-TOLYL)AMINO]PROPANOIC ACIDS, BIS(THIAZOL-5-YL)PHENYL-, BIS(THIAZOL-5-YL)METHANE DERIVATIVES, AND THEIR ANTIMICROBIAL ACTIVITY
    Grybaite, Birute
    Vaickelioniene, Rita
    Stasevych, Maryna
    Komarovska-Porokhnyavets, Olena
    Novikov, Volodymyr
    MickeviCius, Vytautas
    HETEROCYCLES, 2018, 96 (01) : 86 - 105
  • [5] Biological activity of 3-(2-benzoxazol-5-yl)alanine derivatives
    Katarzyna Guzow
    Ewa Mulkiewicz
    Michał Obuchowski
    Wiesław Wiczk
    Amino Acids, 2021, 53 : 1257 - 1268
  • [6] Biological activity of 3-(2-benzoxazol-5-yl)alanine derivatives
    Guzow, Katarzyna
    Mulkiewicz, Ewa
    Obuchowski, Michal
    Wiczk, Wieslaw
    AMINO ACIDS, 2021, 53 (08) : 1257 - 1268
  • [7] Synthesis and antiproliferative activity of some 3-(pyrid-2-yl)-pyrazolines
    Ciupa, Alexander
    De Bank, Paul A.
    Mahon, Mary F.
    Wood, Pauline J.
    Caggiano, Lorenzo
    MEDCHEMCOMM, 2013, 4 (06) : 956 - 961
  • [8] Synthesis and Anticancer Activity Evaluation of (E)-3-{[5-(Aryl)-1,3,4-oxadiazol-2-yl]methyl}-5-(3,4,5-trimethoxybenzylidene)thiazolidine-2,4-diones
    Ashok, D.
    Vanaja, B.
    RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2016, 86 (03) : 681 - 685
  • [9] Synthesis of platinum complexes with 2-(5-perfluoroalkyl-1,2,4-oxadiazol-3yl)-pyridine and 2-(3-perfluoroalkyl-1-methyl-1,2,4-triazole-5yl)-pyridine ligands and their in vitro antitumor activity
    Rubino, Simona
    Pibiri, Ivana
    Costantino, Cristina
    Buscemi, Silvestre
    Girasolo, Maria Assunta
    Attanzio, Alessandro
    Tesoriere, Luisa
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2016, 155 : 92 - 100
  • [10] Synthesis and antitumor activity evaluation of some pyrrolone and pyridazinone heterocycles derived from 3-((2-oxo-5-(p-tolyl)furan-3(2H)-ylidene)methyl)quinolin-2(1H)-one
    El-Helw, Eman A. E.
    Hashem, Ahmed I.
    SYNTHETIC COMMUNICATIONS, 2020, 50 (07) : 1046 - 1055
12345